D4T nucleoside combinations for HIV

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 101-104

  Pollard, Richard B ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; NUCLEOSIDE DERIVATIVE; STAVUDINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030003466     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00929-9     Document Type: Conference Paper

References (6)

1. Dunkle, L., Anderson, R., McLaren, C. et al. (1992) Stavudine (d4T) a promising antiretroviral agent. VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands (Abstract).
2. Anderson, R., Meyer, W., Balch, F. et al. (1992) Antiviral effects of stavudine (d4T) therapy. VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherland, (Abstract).
3. Brett-Smith, H., Griffith, B., Mellons, J., Joiner, K., Mark, R. and Friedland, G. (1992) Effect of d4T on HIV viremia. VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands (Abstract).
4. Petersen, E., Ramirez-Rhonda, C., Schwartz, R. et al. (1992) Findings from a Phase II study of stavudine (d4T). VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands (Abstract).
5. Brett-Smith, H., Griffith, B., Kim, G., Walesky, M. and Friedland, G. (1993) Degree and duration of d4T antiviral effect in human subjects. In: Program and Abstracts of the First National Conference on Human Retroviruses and Related infections. 432, 131 (Abstract).
6. Pollard, R. et al. (1995) Safety of Didanosine plus Stavudine Combination Therapy in HIV-infected Subjects in a Pilot Randomized Double Blinded Trial. Antiviral Res. 26, A302.